Eli Lilly and Company
GITR ANTAGONISTS AND METHODS OF USING THE SAME
Last updated:
Abstract:
The present disclosure relates to compounds that bind to human GITR, pharmaceutical compositions comprising such compounds, and methods of using such compounds.
Status:
Application
Type:
Utility
Filling date:
1 Feb 2022
Issue date:
11 Aug 2022